Metabolon is excited to participate in the 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference being held in San Diego, CA. The conference will bring together individuals from academia and industry who will be presenting their current work in biomarkers, the latest updates on regulatory guidelines and approvals, cancer biomarker validation for clinical application, biomarkers and personalized medicine, impact of big data in translational biomarker research and future of companion diagnostics.
Search
Recent Posts
- ASHG 2024 Recap
- Unlocking Heart Health: How Metabolomics is Transforming the Early Detection of Myocardial Infarction
- Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders
- Metabolon Launches New “Guide to Multiomics” and Accompanying Multiomics Webinar
- Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool
Recent Comments